CHYL Stock Overview
Unified Global Corp. operates as a vertically integrated cannabis company in Canada and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Unified Global Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.001 |
| 52 Week High | US$0.22 |
| 52 Week Low | US$0.001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -93.57% |
| 5 Year Change | -98.75% |
| Change since IPO | -99.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| CHYL | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.1% | 0.06% |
| 1Y | n/a | 20.0% | 22.6% |
Return vs Industry: Insufficient data to determine how CHYL performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how CHYL performed against the US Market.
Price Volatility
| CHYL volatility | |
|---|---|
| CHYL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CHYL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CHYL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Jincao Wu | www.unifiedglobalinc.com |
Unified Global Corp. operates as a vertically integrated cannabis company in Canada and the United States. It engages in the cultivation, supply, and retail of hemp/cannabis products. The company was formerly known as China Senior Living Industry International Holding Corporation and changed its name to Unified Global Corp. The company is based in Denver, Colorado.
Unified Global Corp. Fundamentals Summary
| CHYL fundamental statistics | |
|---|---|
| Market cap | US$59.31k |
| Earnings (TTM) | US$180.15k |
| Revenue (TTM) | US$650.40k |
0.0x
P/E Ratio0.0x
P/S RatioIs CHYL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHYL income statement (TTM) | |
|---|---|
| Revenue | US$650.40k |
| Cost of Revenue | US$408.64k |
| Gross Profit | US$241.76k |
| Other Expenses | US$61.61k |
| Earnings | US$180.15k |
Last Reported Earnings
Sep 30, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CHYL perform over the long term?
See historical performance and comparison